☰

Dawn L. Duval - Publications

Affiliations: 
Clinical Sciences Colorado State University, Fort Collins, CO 
Area:
Oncology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Das S, Idate R, Lana SE, Regan DP, Duval DL. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions. Scientific Reports. 13: 10422. PMID 37369741 DOI: 10.1038/s41598-023-37266-y  0.314
2023 Das S, Idate R, Lana SE, Regan DP, Duval DL. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in genes and fusions. Biorxiv : the Preprint Server For Biology. PMID 36711648 DOI: 10.1101/2023.01.06.522911  0.306
2021 Cronise KE, Das S, Hernandez BG, Regan DP, Dailey DD, McGeachan RI, Lana SE, Page RL, Gustafson DL, Duval DL. Characterizing the Molecular and Immune Landscape of Canine Bladder Cancer. Veterinary and Comparative Oncology. PMID 34021685 DOI: 10.1111/vco.12740  0.334
2021 Alfino LN, Wilczewski-Shirai KC, Cronise KE, Coy J, Glapa K, Ehrhart EJ, Charles JB, Duval DL, Regan DP. Role of Periostin Expression in Canine Osteosarcoma Biology and Clinical Outcome. Veterinary Pathology. 300985821996671. PMID 33685296 DOI: 10.1177/0300985821996671  0.378
2019 Das S, Idate R, Cronise KE, Gustafson DL, Duval DL. Identifying candidate druggable targets in canine cancer cell lines using whole exome sequencing. Molecular Cancer Therapeutics. PMID 31175136 DOI: 10.1158/1535-7163.Mct-18-1346  0.461
2019 Cronise KE, Hernandez BG, Gustafson DL, Duval DL. Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer. Molecular Pharmacology. PMID 31048548 DOI: 10.1124/Mol.119.115808  0.426
2018 Gustafson DL, Duval DL, Regan DP, Thamm DH. Canine Sarcomas as a Surrogate for the Human Disease. Pharmacology & Therapeutics. PMID 29378221 DOI: 10.1016/J.Pharmthera.2018.01.012  0.373
2017 Cronise K, Hernandez B, Gustafson DL, Duval DL. Abstract 324: Investigating the dependence of canine bladder transitional cell carcinoma on activated mutant BRAF Cancer Research. 77: 324-324. DOI: 10.1158/1538-7445.Am2017-324  0.493
2016 Fowles JS, Dailey DD, Gustafson DL, Thamm DH, Duval DL. The Flint Animal Cancer Center (FACC) Canine Tumour Cell Line Panel: a resource for veterinary drug discovery, comparative oncology and translational medicine. Veterinary and Comparative Oncology. PMID 27197945 DOI: 10.1111/Vco.12192  0.459
2016 Fowles JS, Brown KC, Hess AM, Duval DL, Gustafson DL. Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma. Bmc Bioinformatics. 17: 93. PMID 26892349 DOI: 10.1186/S12859-016-0942-8  0.454
2016 Hernandez B, Cronise K, Costello JC, Page R, Lana S, Jones KL, Duval DL. Abstract 617: Canine transitional cell carcinoma of the bladder expresses activated BRAF, but is not sensitive to vemurafenib Cancer Research. 76: 617-617. DOI: 10.1158/1538-7445.Am2016-617  0.39
2015 Dailey DD, Ehrhart EJ, Duval DL, Bass T, Powers BE. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors. Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. 27: 268-77. PMID 25862711 DOI: 10.1177/1040638715578878  0.388
2015 Gustafson DL, Fowles JS, Thamm DH, Page RL, Duval DL. Abstract 5136: The Flint Animal Cancer Center (FACC) canine tumor cell line panel: A resource for comparative and translational oncology Cancer Research. 75: 5136-5136. DOI: 10.1158/1538-7445.Am2015-5136  0.555
2015 Fowles JS, Brown KC, Hess AM, Duval DL, Gustafson DL. Abstract 2179: Gene expression models for predicting doxorubicin response in canine osteosarcoma Cancer Research. 75: 2179-2179. DOI: 10.1158/1538-7445.Am2015-2179  0.317
2014 Halsey CH, Gustafson DL, Rose BJ, Wolf-Ringwall A, Burnett RC, Duval DL, Avery AC, Thamm DH. Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor. Bmc Veterinary Research. 10: 105. PMID 24885200 DOI: 10.1186/1746-6148-10-105  0.403
2014 Fowles JS, Hess AM, Duval DL, Thamm DH, Gustafson DL. Abstract A30: Interspecies applications of gene expression-based prediction of chemosensitivity Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-A30  0.493
2014 Pfaff LE, Kalet BT, Dailey DD, Duval DL. Abstract A23: Insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) drives growth, metastasis and chemoresistance in human and canine osteosarcoma Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-A23  0.515
2013 Kalet BT, Anglin SR, Handschy A, O'Donoghue LE, Halsey C, Chubb L, Korch C, Duval DL. Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors. Plos One. 8: e68815. PMID 23874775 DOI: 10.1371/Journal.Pone.0068815  0.676
2013 Dailey DD, Anfinsen KP, Pfaff LE, Ehrhart EJ, Charles JB, Bønsdorff TB, Thamm DH, Powers BE, Jonasdottir TJ, Duval DL. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors. Bmc Veterinary Research. 9: 130. PMID 23816051 DOI: 10.1186/1746-6148-9-130  0.495
2013 Kalet BT, O'Donoghue LE, Duval DL. Abstract 3008: IGF2 mRNA binding protein 1 drives growth, metastasis and chemoresistance in osteosarcoma. Cancer Research. 73: 3008-3008. DOI: 10.1158/1538-7445.Am2013-3008  0.688
2013 Fowles JS, Hess AM, Duval DL, Gustafson DL. Abstract 2890: NCI60-based gene expression models for predicting chemosensitivity in canine cancer. Cancer Research. 73: 2890-2890. DOI: 10.1158/1538-7445.Am2013-2890  0.469
2011 O'Donoghue LE, Rivest JP, Duval DL. Polymerase chain reaction-based species verification and microsatellite analysis for canine cell line validation. Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. 23: 780-5. PMID 21908323 DOI: 10.1177/1040638711408064  0.657
2011 Angstadt AY, Motsinger-Reif A, Thomas R, Kisseberth WC, Guillermo Couto C, Duval DL, Nielsen DM, Modiano JF, Breen M. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart. Genes, Chromosomes & Cancer. 50: 859-74. PMID 21837709 DOI: 10.1002/Gcc.20908  0.374
2011 Duval DL. PRKA/AMPK: integrating energy status with fertility in pituitary gonadotrophs. Biology of Reproduction. 84: 205-6. PMID 21084710 DOI: 10.1095/Biolreprod.110.089722  0.324
2010 O'Donoghue LE, Ptitsyn AA, Kamstock DA, Siebert J, Thomas RS, Duval DL. Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome. Bmc Cancer. 10: 506. PMID 20860831 DOI: 10.1186/1471-2407-10-506  0.658
2010 Sottnik JL, Duval DL, Ehrhart EJ, Thamm DH. An orthotopic, postsurgical model of luciferase transfected murine osteosarcoma with spontaneous metastasis. Clinical & Experimental Metastasis. 27: 151-60. PMID 20213324 DOI: 10.1007/S10585-010-9318-Z  0.44
2010 Jean A, Gutierrez-Hartmann A, Duval DL. A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter. Molecular Endocrinology (Baltimore, Md.). 24: 91-103. PMID 19887646 DOI: 10.1210/Me.2009-0279  0.3
2007 Gutierrez-Hartmann A, Duval DL, Bradford AP. ETS transcription factors in endocrine systems. Trends in Endocrinology and Metabolism: Tem. 18: 150-8. PMID 17387021 DOI: 10.1016/J.Tem.2007.03.002  0.35
2000 Duval DL, Farris AR, Quirk CC, Nett TM, Hamernik DL, Clay CM. Responsiveness of the ovine gonadotropin-releasing hormone receptor gene to estradiol and gonadotropin-releasing hormone is not detectable in vitro but is revealed in transgenic mice. Endocrinology. 141: 1001-10. PMID 10698176 DOI: 10.1210/Endo.141.3.7391  0.377
1999 White BR, Duval DL, Mulvaney JM, Roberson MS, Clay CM. Homologous regulation of the gonadotropin-releasing hormone receptor gene is partially mediated by protein kinase C activation of an activator protein-1 element. Molecular Endocrinology (Baltimore, Md.). 13: 566-77. PMID 10194763 DOI: 10.1210/Mend.13.4.0262  0.376
1999 Duval DL, Ellsworth BS, Clay CM. Is gonadotrope expression of the gonadotropin releasing hormone receptor gene mediated by autocrine/paracrine stimulation of an activin response element? Endocrinology. 140: 1949-52. PMID 10098536 DOI: 10.1210/Endo.140.4.6780  0.396
1997 Duval DL, Nelson SE, Clay CM. The tripartite basal enhancer of the gonadotropin-releasing hormone (GnRH) receptor gene promoter regulates cell-specific expression through a novel GnRH receptor activating sequence. Molecular Endocrinology (Baltimore, Md.). 11: 1814-21. PMID 9369449 DOI: 10.1210/Mend.11.12.0020  0.389
1997 Duval DL, Nelson SE, Clay CM. A binding site for steroidogenic factor-1 is part of a complex enhancer that mediates expression of the murine gonadotropin-releasing hormone receptor gene. Biology of Reproduction. 56: 160-8. PMID 9002645 DOI: 10.1095/Biolreprod56.1.160  0.39
Show low-probability matches.